标题
DNA Repair Pathways in Cancer Therapy and Resistance
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-02-09
DOI
10.3389/fphar.2020.629266
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction
- (2020) Elena Clementi et al. BMC BIOLOGY
- Biomarker-Guided Development of DNA Repair Inhibitors
- (2020) James M. Cleary et al. MOLECULAR CELL
- MGMT expression affects the gemcitabine resistance of pancreatic cancer cells
- (2020) Yu Shi et al. LIFE SCIENCES
- MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer
- (2019) Xiaowei Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
- (2019) Panagiotis A Konstantinopoulos et al. LANCET ONCOLOGY
- Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer
- (2019) Nicole M. Kettner et al. CLINICAL CANCER RESEARCH
- Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
- (2019) Jianhui Ma et al. CANCER CELL
- Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer
- (2019) J F Liu et al. ANNALS OF ONCOLOGY
- N6-methylation of adenosine (m6A) of FZD10 mRNA contributes to PARP inhibitor resistance
- (2019) Takeshi Fukumoto et al. CANCER RESEARCH
- PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
- (2019) Constantia Pantelidou et al. Cancer Discovery
- Berberine attenuates XRCC1‐mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs
- (2019) Xingjie Gao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- ATM in DNA repair in cancer
- (2019) Mei Hua Jin et al. PHARMACOLOGY & THERAPEUTICS
- Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
- (2019) Stefan Gröschel et al. Nature Communications
- Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer
- (2019) Carino Gurjao et al. Cancer Immunology Research
- Anti-tumor activity and mechanistic characterization of APE1/Ref-1 inhibitors in bladder cancer
- (2019) Melissa L. Fishel et al. MOLECULAR CANCER THERAPEUTICS
- ALDH1A1 contributes to PARP inhibitor resistance via enhancing DNA repair in BRCA2-/- ovarian cancer cells
- (2019) Lu Liu et al. MOLECULAR CANCER THERAPEUTICS
- Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
- (2019) Robert L. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
- (2019) Anna F. Farago et al. Cancer Discovery
- Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
- (2019) Zachary L. Watson et al. Clinical Epigenetics
- Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models
- (2019) Hannah C. Wise et al. Scientific Reports
- APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
- (2019) Casey D. Stefanski et al. NEOPLASIA
- Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
- (2018) Ewa Gogola et al. CANCER CELL
- The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis
- (2018) Anna Lee et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
- (2018) Min Yuen Teo et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcriptional control of O6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma
- (2018) Caroline Happold et al. JOURNAL OF NEUROCHEMISTRY
- Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
- (2018) Sibylle Loibl et al. LANCET ONCOLOGY
- miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation
- (2018) Christianne Hoey et al. Molecular Oncology
- Loss of E2F7 confers resistance to poly-ADP-ribose polymerase (PARP) inhibitors in BRCA2-deficient cells
- (2018) Kristen E Clements et al. NUCLEIC ACIDS RESEARCH
- Glucose starvation impairs DNA repair in tumour cells selectively by blocking histone acetylation
- (2018) Rena Ampferl et al. RADIOTHERAPY AND ONCOLOGY
- The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
- (2018) Stephen T. Durant et al. Science Advances
- Mitochondrial DNA D‑loop lesions with the enhancement of DNA repair contribute to gastrointestinal cancer progression
- (2018) Bishi Wang et al. ONCOLOGY REPORTS
- Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells
- (2018) Shih-Han Hsu et al. BIOCHEMICAL PHARMACOLOGY
- DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
- (2018) Juan Ruiz-Bañobre et al. GASTROENTEROLOGY
- USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors
- (2018) Kah Suan Lim et al. MOLECULAR CELL
- The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers
- (2018) Antonio Marzio et al. MOLECULAR CELL
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA damage related crosstalk between the nucleus and mitochondria
- (2017) Mohammad Saki et al. FREE RADICAL BIOLOGY AND MEDICINE
- The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
- (2017) Maryam Moradi Binabaj et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
- (2017) Toni Rose Jue et al. Journal of Translational Medicine
- Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Yung-Jue Bang et al. LANCET ONCOLOGY
- Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
- (2017) Giovanni Germano et al. NATURE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
- (2017) Nadeem Riaz et al. Nature Communications
- Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors
- (2017) David Quigley et al. Cancer Discovery
- Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression
- (2017) Anna Di Benedetto et al. Scientific Reports
- Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes
- (2017) Thai Q. Tran et al. PLOS BIOLOGY
- A Multikinase and DNA-PK Inhibitor Combination Immunomodulates Melanomas, Suppresses Tumor Progression, and Enhances Immunotherapies
- (2017) Alexander K. Tsai et al. Cancer Immunology Research
- RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells
- (2017) Harry O. King et al. Stem Cell Reports
- Acidic cellular microenvironment modifies carcinogen-induced DNA damage and repair
- (2016) Q. Shi et al. ARCHIVES OF TOXICOLOGY
- PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions
- (2016) G E Konecny et al. BRITISH JOURNAL OF CANCER
- The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models
- (2016) L. Oplustil O'Connor et al. CANCER RESEARCH
- Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair
- (2016) Shigeaki Sunada et al. CANCER SCIENCE
- NU7441 Enhances the Radiosensitivity of Liver Cancer Cells
- (2016) Chuanjie Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Synthetic lethality: the road to novel therapies for breast cancer
- (2016) Kiranjit K Dhillon et al. ENDOCRINE-RELATED CANCER
- Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic
- (2016) Aniello Cerrato et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
- (2016) Petra ter Brugge et al. JNCI-Journal of the National Cancer Institute
- BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells
- (2016) S V Muralidharan et al. ONCOGENE
- Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine
- (2016) Nancy L. Oleinick et al. RADIOTHERAPY AND ONCOLOGY
- Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models ofMLL-rearranged AML
- (2016) Isabel Morgado-Palacin et al. Science Signaling
- The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
- (2016) Hailong Zhao et al. World Journal of Surgical Oncology
- Targeting DNA Repair in Cancer: Beyond PARP Inhibitors
- (2016) Jessica S. Brown et al. Cancer Discovery
- Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
- (2016) Petra ter Brugge et al. JNCI-Journal of the National Cancer Institute
- Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models ofMLL-rearranged AML
- (2016) Isabel Morgado-Palacin et al. Science Signaling
- Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response
- (2016) Danish Memon et al. npj Genomic Medicine
- DNA damage response – A double-edged sword in cancer prevention and cancer therapy
- (2015) Hui Tian et al. CANCER LETTERS
- Mitochondrial DNA Repair through OGG1 Activity Attenuates Breast Cancer Progression and Metastasis
- (2015) L. V. Yuzefovych et al. CANCER RESEARCH
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
- (2015) G. Kim et al. CLINICAL CANCER RESEARCH
- Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy
- (2015) Corrado Iaccarino et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells
- (2015) Pang-ning Teng et al. GYNECOLOGIC ONCOLOGY
- DNA-PKcs Deficiency Inhibits Glioblastoma Cell-Derived Angiogenesis After Ionizing Radiation
- (2015) Yang Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide
- (2015) O. Erice et al. MOLECULAR CANCER THERAPEUTICS
- Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme
- (2015) Sayan Mullick Chowdhury et al. Nanomedicine-Nanotechnology Biology and Medicine
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- MGMT Inhibition Suppresses Survivin Expression in Pancreatic Cancer
- (2015) George C. Bobustuc et al. PANCREAS
- ATM and ATR as therapeutic targets in cancer
- (2015) Anika Maria Weber et al. PHARMACOLOGY & THERAPEUTICS
- Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
- (2015) Linda Henneman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis
- (2015) Nicholas Jette et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Combining carbon ion irradiation and non-homologous end-joining repair inhibitor NU7026 efficiently kills cancer cells
- (2015) Hongyu Ma et al. Radiation Oncology
- DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells
- (2015) M. Emmy M. Dolman et al. PLoS One
- Targeting DNA damage response in cancer therapy
- (2014) Noriko Hosoya et al. CANCER SCIENCE
- Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
- (2014) Ross Carruthers et al. Molecular Oncology
- A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts
- (2014) Fei Huang et al. PLoS One
- DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
- (2013) Wojciech M. Ciszewski et al. BREAST CANCER RESEARCH AND TREATMENT
- ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
- (2013) L. Biddlestone-Thorpe et al. CLINICAL CANCER RESEARCH
- Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity
- (2013) Kevin M. Foote et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
- (2013) A. D. Guertin et al. MOLECULAR CANCER THERAPEUTICS
- Optimizing Glioblastoma Temozolomide Chemotherapy Employing Lentiviral-based Anti-MGMT shRNA Technology
- (2013) Thomas Viel et al. MOLECULAR THERAPY
- Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress
- (2013) Y Cheng et al. Cell Death & Disease
- Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide
- (2012) Ana P. Montaldi et al. CLINICAL AND EXPERIMENTAL MEDICINE
- MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated With Temozolomide-Based Chemoradiotherapy: A Single-Institution Study
- (2012) Young Suk Kim et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Low p53 Binding Protein 1 (53BP1) Expression Is Associated With Increased Local Recurrence in Breast Cancer Patients Treated With Breast-Conserving Surgery and Radiotherapy
- (2012) Hanmanth J.R. Neboori et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Colorectal and Other Cancer Risks for Carriers and Noncarriers From Families With a DNA Mismatch Repair Gene Mutation: A Prospective Cohort Study
- (2012) Aung Ko Win et al. JOURNAL OF CLINICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy
- (2011) Li-E Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-Induced Epigenetic Regulation and Silencing of the BRCA1 Promoter
- (2011) Y. Lu et al. MOLECULAR AND CELLULAR BIOLOGY
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
- (2010) Massimo Squatrito et al. CANCER CELL
- Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
- (2010) T. G. Oliver et al. GENES & DEVELOPMENT
- DNA Damage Response
- (2010) G. Giglia-Mari et al. Cold Spring Harbor Perspectives in Biology
- Essential Role of DNA Base Excision Repair on Survival in an Acidic Tumor Microenvironment
- (2009) Y. Seo et al. CANCER RESEARCH
- Targeting the DNA damage response for cancer therapy
- (2009) Simon N. Powell et al. DNA REPAIR
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation
- (2009) John P Alao et al. Radiation Oncology
- Enhancement of apoptotic damage of squamous cell carcinoma cells by inhibition of the mitochondrial DNA repairing system
- (2008) Eisaku Ueta et al. CANCER SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started